ClinicalTrials.Veeva

Menu

Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging)

Johns Hopkins University logo

Johns Hopkins University

Status

Terminated

Conditions

SLE (Systemic Lupus)

Treatments

Device: MRI

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT06445127
IRB00354110

Details and patient eligibility

About

This study is being done to find out if a non-invasive Magnetic Resonance Imaging (MRI) examination of the kidneys may be helpful in patients with systemic lupus erythematosus (SLE).

Enrollment

15 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male and female adults over the age of 18 who have been diagnosed with SLE and are able to undergo a kidney MRI.

Exclusion criteria

  • Any patient that has undergone a renal transplant.
  • Any patient that is receiving renal dialysis

Trial design

15 participants in 3 patient groups

Known Lupus Nephritis, with elevated UPCR result
Description:
Patients will have one scan at baseline, and one every 4 weeks thereafter for 3 visits. The final imaging session is after 6 months of routine therapy.
No known lupus nephritis
Description:
Patients will have one MRI
Known Lupus Nephritis, with normal Urine Protein Creatinine Ratio (UPCR) result
Description:
Patients will have one scan at baseline, and one every 4 weeks thereafter for 3 visits.

Trial contacts and locations

1

Loading...

Central trial contact

Homa Timlin, MD, MSc, MRCP, CCST

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems